| Brand Name | Innovexia Life Sciences |
|---|---|
| Industry / Business Category | Healthcare Products / Pharma Franchise (PCD) |
| Founded Year | 2011 |
| Franchise Started Year | 2012 |
| Total Franchise Outlets | 10–20 |
| Estimated Investment | INR 5 Lakh – 10 Lakh |
| Franchise Fee | INR 150,000 |
| Royalty Fee | 35% |
| Space Requirement | Not specified; typically requires a small office or pharma storage facility |
| Expected Payback Period | 1–10 Years |
Innovexia Life Sciences is a PCD (Propaganda Cum Distribution) pharmaceutical company operating in the healthcare sector. It manufactures and distributes a wide range of medicines and healthcare products, including tablets, capsules, injectables, syrups, ointments, protein powders, nutraceuticals, and Ayurvedic formulations. Its market segment includes pharmacies, healthcare professionals, and franchise entrepreneurs seeking PCD pharma opportunities.
The business functions through manufacturing, distribution, and franchise operations. Medicines are produced at ISO and GMP-certified facilities, ensuring quality compliance. Franchise partners operate as local distributors, managing product promotion, sales, and delivery to pharmacies or healthcare providers. Revenue is generated through product sales, franchise fees, and ongoing royalty contributions.
| Tablets and Capsules | Formulated for efficacy and patient compliance |
|---|---|
| Injectables | Safe and regulated medicinal delivery |
| Syrups and Ointments | Therapeutic applications for diverse healthcare needs |
| Protein Powders and Nutraceuticals | Health and wellness support |
| Ayurvedic Products | Combination of traditional remedies and modern formulations |
Franchise partners act as local distributors with exclusive rights in assigned territories. Responsibilities include marketing, sales, inventory management, and client support. The franchisor provides product supply, promotional materials, operational guidance, and technical support. This model allows franchisees to operate independently while leveraging Innovexia’s established brand credibility.
Franchise costs and investment include initial brand onboarding, stock procurement, and promotional setup:
| Estimated Investment | INR 5–10 Lakh |
|---|---|
| Franchise Fee | INR 150,000 |
| Royalty | 35% on revenue |
| Setup Cost Components | Office setup, inventory procurement, marketing materials, and basic distribution logistics |
| Typical Space Requirement | Small office or warehouse space suitable for pharma stock storage |
|---|---|
| Preferred Locations | Areas with access to pharmacies and healthcare providers |
| Equipment Needs | Shelving, storage facilities, basic office infrastructure |
| Staffing Considerations | Personnel for sales, inventory management, and client coordination |
Innovexia provides a comprehensive support system including:
Revenue for franchise partners is generated through wholesale product sales to pharmacies and healthcare professionals. Monopoly rights in assigned areas help minimize local competition. ROI depends on sales volume, client network, and effective territory management. Payback period can range from 1 to 10 years based on market penetration and sales performance.
| Established Year | 2011 |
|---|---|
| Franchise Commenced | 2012 |
| Current Franchise Network | 10–20 outlets |
| Geographic Reach | Primarily India, expanding in multiple regions |
| Expansion Strategy | Growth through PCD franchise partnerships and strategic distribution collaborations with pharmacies and healthcare professionals |
Innovexia Life Sciences combines certified manufacturing facilities (ISO, GMP, WHO) with an extensive product portfolio and a PCD franchise model. Unlike typical pharmaceutical businesses, it emphasizes exclusive territory rights, comprehensive franchise support, and a broad product range that includes both allopathic and Ayurvedic products, giving franchisees a diversified healthcare offering in a single territory.
This profile provides a neutral, factual overview of Innovexia Life Sciences and its PCD franchise model, offering investors clear insights into operations, investment, and business potential.
Estimated investment ranges from INR 5–10 Lakh, with a franchise fee of INR 150,000 and 35% royalty on revenue.
Franchise partners manage distribution, sales, and marketing in an assigned territory while receiving product supply and support from the franchisor.
Franchise outlets require a small office or storage area suitable for pharma stock and administrative operations.
Payback period ranges from 1 to 10 years, depending on sales volume, territory size, and client acquisition.
Investors can contact Innovexia Life Sciences directly to discuss territory assignment, franchise terms, and onboarding procedures. ## Similar Franchise Opportunities
Disclaimer: All scores, rankings, and estimates on ForeFind are independently produced editorial assessments using publicly available data and validated brand-submitted information. They are not verified facts, financial advice, or investment recommendations. Full Disclaimer.